23andMe's Fatal Flaw | Defying Gravity? | 2
Business Wars18 Juni 2025

23andMe's Fatal Flaw | Defying Gravity? | 2

Plagued by low sales of its genetic tests, 23andMe adopts a bold new plan: slash prices and enter the pharmaceutical industry. But with investors nervous, can CEO Anne Wojcicki keep the show going long enough to make her DNA dream pay off?

Be the first to know about Wondery’s newest podcasts, curated recommendations, and more! Sign up now at https://wondery.fm/wonderynewsletter

Listen to Business Wars on the Wondery App or wherever you get your podcasts. Experience all episodes ad-free and be the first to binge the newest season. Unlock exclusive early access by joining Wondery+ in the Wondery App or on Apple Podcasts. Start your free trial today by visiting wondery.com/links/business-wars/ now.


See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Avsnitt(663)

The Many Deaths of Dungeons & Dragons | A Kingdom Reborn | 2

The Many Deaths of Dungeons & Dragons | A Kingdom Reborn | 2

After years of falling sales, Dungeons & Dragons’ publisher TSR is being dragged under by massive debts and in need of rescue. But as hopelessness takes hold, TSR boss Lorraine Williams resorts to des...

10 Dec 202538min

The Many Deaths of Dungeons & Dragons | Wizards and Witch Hunts | 1

The Many Deaths of Dungeons & Dragons | Wizards and Witch Hunts | 1

When Gary Gygax and his gaming pal Dave Arneson create Dungeons & Dragons, he believes he’s onto something special and starts a business called TSR to publish it. But when TSR publishes the game, he m...

3 Dec 202543min

Ozempic Wars | The Next Injection | 2

Ozempic Wars | The Next Injection | 2

Novo Nordisk can't keep up with demand for Ozempic and Wegovy, giving competitor Eli Lilly the edge in the GLP-1 market. And off-brand competitors continue to hammer the company's market position. Lay...

26 Nov 202536min

Ozempic Wars | The Hundred-Year Duel | 1

Ozempic Wars | The Hundred-Year Duel | 1

When pharmaceutical giant Novo Nordisk developed a new medication for type 2 diabetes, they noticed that a welcome side effect was a small amount of weight loss. They had no idea that their new diabet...

19 Nov 202534min

Gap's Revival | Better in Navy?  | 3

Gap's Revival | Better in Navy? | 3

The “Better in Denim” ad campaign put Gap back on the map for Gen Z — but are viral ads enough to fuel a comeback? Jordyn Holman of the New York Times breaks down how Gap CEO Richard Dickson is taking...

13 Nov 202539min

Gap's Revival | Back in Blue | 2

Gap's Revival | Back in Blue | 2

It’s late 2023, and Gap’s new CEO Richard Dickson is trying to revive the brand’s fading fortunes. Dickson is the man who rescued Barbie from cultural irrelevance and turned her into a blockbuster mov...

12 Nov 202538min

Gap's Revival | Faded Khakis | 1

Gap's Revival | Faded Khakis | 1

It’s 2016, and a fire is ripping through a Gap distribution center in Fishkill, New York. When the smoke clears, thousands of Gap T-shirts, khakis, and jeans are reduced to ash. But one analyst sees g...

5 Nov 202542min

How Lululemon Won Athleisure | Mirror, Mirror | 2

How Lululemon Won Athleisure | Mirror, Mirror | 2

It's the 2010s, and the athleisure market has exploded. As Lululemon has grown into one of the world's biggest athletic wear companies, brands like Nike and Adidas want a piece of the pie—and new, sma...

29 Okt 202533min

Populärt inom Business & ekonomi

badfluence
framgangspodden
varvet
rss-jossan-nina
uppgang-och-fall
rss-borsens-finest
avanzapodden
fill-or-kill
svd-tech-brief
rss-inga-dumma-fragor-om-pengar
dynastin
rss-svart-marknad
bathina-en-podcast
lastbilspodden
borsmorgon
rss-kort-lang-analyspodden-fran-di
montrosepodden
24fragor
kapitalet-en-podd-om-ekonomi
rss-dagen-med-di